Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Reynes

Showing results (71-80 of 200) with videos related to

Pageof 20
Sort By:
Current HIV Research|July 16, 2009
How do HIV-infected smokers react to cigarette price increases? Evidence from the APROCO-COPILOTE-ANRS CO8 CohortPatrick Peretti-Watel, Virginie Villes, Xavier Duval, et al.
The Journal of Infectious Diseases|December 16, 2003
Enfuvirtide (T-20) cross-reactive glycoprotein 41 antibody does not impair the efficacy or safety of enfuvirtideSharon Walmsley, Keith Henry, Christine Katlama, et al.
AIDS (London, England)|June 29, 2013
Dolutegravir in antiretroviral-naive adults with HIV-1: 96-week results from a randomized dose-ranging studyHans-Jürgen Stellbrink, Jacques Reynes, Adriano Lazzarin, et al.
AIDS Research and Human Retroviruses|September 1, 2011
Peroxisome proliferator activating receptor alpha and gamma polymorphisms and metabolic abnormalities in HIV-infected patients receiving highly active antiretroviral therapy: the ANRS CO8 APROCO-COPILOTE studyHassan Nazih, François Raffi, Audrey Taïeb, et al.
Immunity & Ageing : I & A|March 14, 2024
Immune profiles of pre-frail people living with HIV-1: a prospective longitudinal studyLucy Kundura, Renaud Cezar, Sandrine Gimenez, et al.
HIV Clinical Trials|December 4, 2010
Impact on health-related quality of life of a switch from enfuvirtide to raltegravir among multidrug-resistant HIV-1-infected patients: a randomized open-label trial (EASIER-ANRS 138)Thomas Boulet, Juliette Pavie, Isabelle Charreau, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 25, 2016
Lung Cancer Screening with Chest Computed Tomography in People Living with HIV: A Review by the Multidisciplinary CANCERVIH Working GroupAlain Makinson, Vincent Le Moing, Jacques Reynes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 24, 2007
Posaconazole for the treatment of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infectionDaniel J Skiest, Jose A Vazquez, Gregory M Anstead, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 5, 2020
Abnormal liver tests in patients hospitalized with Coronavirus disease 2019: Should we worry?Magdalena Meszaros, Lucy Meunier, David Morquin, et al.
JAMA Internal Medicine|April 12, 2016
Long-term Immune Response to Hepatitis B Virus Vaccination Regimens in Adults With Human Immunodeficiency Virus 1: Secondary Analysis of a Randomized Clinical TrialOdile Launay, Arielle R Rosenberg, David Rey, et al.
Pageof 20

Showing results (71-80 of 200) with videos related to

Sort By:
Pageof 20
Current HIV Research|July 16, 2009
How do HIV-infected smokers react to cigarette price increases? Evidence from the APROCO-COPILOTE-ANRS CO8 CohortPatrick Peretti-Watel, Virginie Villes, Xavier Duval, et al.
The Journal of Infectious Diseases|December 16, 2003
Enfuvirtide (T-20) cross-reactive glycoprotein 41 antibody does not impair the efficacy or safety of enfuvirtideSharon Walmsley, Keith Henry, Christine Katlama, et al.
AIDS (London, England)|June 29, 2013
Dolutegravir in antiretroviral-naive adults with HIV-1: 96-week results from a randomized dose-ranging studyHans-Jürgen Stellbrink, Jacques Reynes, Adriano Lazzarin, et al.
AIDS Research and Human Retroviruses|September 1, 2011
Peroxisome proliferator activating receptor alpha and gamma polymorphisms and metabolic abnormalities in HIV-infected patients receiving highly active antiretroviral therapy: the ANRS CO8 APROCO-COPILOTE studyHassan Nazih, François Raffi, Audrey Taïeb, et al.
Immunity & Ageing : I & A|March 14, 2024
Immune profiles of pre-frail people living with HIV-1: a prospective longitudinal studyLucy Kundura, Renaud Cezar, Sandrine Gimenez, et al.
HIV Clinical Trials|December 4, 2010
Impact on health-related quality of life of a switch from enfuvirtide to raltegravir among multidrug-resistant HIV-1-infected patients: a randomized open-label trial (EASIER-ANRS 138)Thomas Boulet, Juliette Pavie, Isabelle Charreau, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 25, 2016
Lung Cancer Screening with Chest Computed Tomography in People Living with HIV: A Review by the Multidisciplinary CANCERVIH Working GroupAlain Makinson, Vincent Le Moing, Jacques Reynes, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 24, 2007
Posaconazole for the treatment of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infectionDaniel J Skiest, Jose A Vazquez, Gregory M Anstead, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 5, 2020
Abnormal liver tests in patients hospitalized with Coronavirus disease 2019: Should we worry?Magdalena Meszaros, Lucy Meunier, David Morquin, et al.
JAMA Internal Medicine|April 12, 2016
Long-term Immune Response to Hepatitis B Virus Vaccination Regimens in Adults With Human Immunodeficiency Virus 1: Secondary Analysis of a Randomized Clinical TrialOdile Launay, Arielle R Rosenberg, David Rey, et al.
Pageof 20